Morgan Stanley initiated coverage of Rockwell Medical Inc. (Nasdaq: RMTI) with an Underweight rating and a $7 price target sending the stock price plummeting $2.20 to close at $11.54.
Rockwell initiated with Underweight
August 13, 2015 at 12:16 PM EDT